» Articles » PMID: 22205820

Pooling Nasopharyngeal/throat Swab Specimens to Increase Testing Capacity for Influenza Viruses by PCR

Overview
Specialty Microbiology
Date 2011 Dec 30
PMID 22205820
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Real-time PCR methodology can be applied to rapidly and accurately detect influenza viruses. During times of surge testing or enhanced pandemic surveillance, public health laboratories (PHLs) may experience overwhelming demand for testing, even while the prevalence of positive specimens remains low. To improve laboratory capacity and testing efficiency during surges, we evaluated whether nasopharyngeal (NP)/throat swab specimens can be pooled and tested for the presence of the 2009 H1N1 influenza virus without a reduction in sensitivity. Pools of 10 specimens were extracted and concentrated upon elution on the MagNA Pure LC instrument, and real-time PCR was performed on the Applied Biosystems 7500 Fast platform, using the CDC swine influenza virus real-time RT-PCR detection panel (rRT-PCR swine flu panel). Specimens in positive pools were singly re-extracted and retested by PCR to identify individual positive samples. Initial studies showed that spiking a pool of nine negative specimens (100 μl each) or 900 μl of virus transport medium with 100 μl of a positive clinical specimen caused no loss of sensitivity by rRT-PCR testing. Pools containing either multiple positive specimens or specimens positive for other respiratory viruses also showed no negative effect on crossing threshold (C(T)) values. To test the robustness of the pooling protocol, a panel of 50 blinded samples was sent to three PHLs and tested in five pools of 10. All PHLs correctly identified the positive specimens. This study demonstrates the feasibility of using a pooling strategy to increase capacity and conserve resources during surge testing and periods of enhanced influenza surveillance when the prevalence is low.

Citing Articles

Evaluation of Fecal Sample Pooling for Real-Time RT-PCR Testing SARS-CoV-2 in Animals.

Leonardi-Cattolica A, Kayastha S, Miller M, Guag J, Tkachenko A, Lowe J Viruses. 2024; 16(11).

PMID: 39599766 PMC: 11599033. DOI: 10.3390/v16111651.


Transmission of Swine Influenza A Viruses along Pig Value Chains, Cambodia, 2020-2022.

Hidano A, Koeut D, Holt H, Leung W, Krean S, Chhim V Emerg Infect Dis. 2024; 30(12):2669-2673.

PMID: 39592446 PMC: 11616665. DOI: 10.3201/eid3012.240695.


binGroup2: Statistical Tools for Infection Identification via Group Testing.

Bilder C, Hitt B, Biggerstaff B, Tebbs J, McMahan C R J. 2024; 15(4):21-36.

PMID: 38818016 PMC: 11139028. DOI: 10.32614/rj-2023-081.


Additive partially linear model for pooled biomonitoring data.

Mou X, Wang D Comput Stat Data Anal. 2024; 190.

PMID: 38187953 PMC: 10769007. DOI: 10.1016/j.csda.2023.107862.


Accelerating the Laboratory Testing Capacity through Saliva Pooling Prior to Direct RT-qPCR for SARS-CoV-2 Detection.

Kaisar M, Jonnatan S, Widowati T, Kristin H, Vasandani S, Mahendra C Diagnostics (Basel). 2022; 12(12).

PMID: 36553167 PMC: 9777453. DOI: 10.3390/diagnostics12123160.


References
1.
Gintowt A, Germer J, Mitchell P, Yao J . Evaluation of the MagNA Pure LC used with the TRUGENE HBV Genotyping Kit. J Clin Virol. 2005; 34(2):155-7. DOI: 10.1016/j.jcv.2005.05.008. View

2.
Emmanuel J, Bassett M, Smith H, Jacobs J . Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol. 1988; 41(5):582-5. PMC: 1141517. DOI: 10.1136/jcp.41.5.582. View

3.
Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R . The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Microbiol Immunol. 2001; 45(9):667-72. DOI: 10.1111/j.1348-0421.2001.tb01300.x. View

4.
Garcia Z, Taylor L, Ruano A, Pavon L, Ayerdis E, Luftig R . Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. J Med Virol. 1996; 49(3):218-22. DOI: 10.1002/(SICI)1096-9071(199607)49:3<218::AID-JMV10>3.0.CO;2-8. View

5.
Roth W, Weber M, Buhr S, Drosten C, Weichert W, Sireis W . Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion. 2002; 42(7):862-8. DOI: 10.1046/j.1537-2995.2002.00129.x. View